The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 17, 2018

Filed:

Nov. 13, 2014
Applicant:

Laila Pharmaceuticals Pvt. Ltd., Vijayawada, IN;

Inventors:

Ravichandran Sripathy, Vijayawada, IN;

Venkata Narasimha Siva Rama Raju Mandapati, Vijayawada, IN;

Gopaal Ajay, Vijayawada, IN;

Nirvanashetty Somashekara, Vijayawada, IN;

Ramchand Nanappan Chaniyilparampu, Vijayawada, IN;

Rama Raju Gokaraju, Vijayawada, IN;

Ganga Raju Gokaraju, Vijayawada, IN;

Kiran Bhupathiraju, Vijayawada, IN;

Dwarakanath Anjana, Vijayawada, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/9066 (2006.01); A61K 9/51 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 9/107 (2006.01); A61K 36/9068 (2006.01); A61K 36/16 (2006.01); A61K 36/185 (2006.01); A61K 36/258 (2006.01); A61K 36/38 (2006.01); A61K 36/53 (2006.01); A61K 31/12 (2006.01); A61K 31/047 (2006.01); A61K 31/05 (2006.01); A61K 31/122 (2006.01); A61K 31/19 (2006.01); A61K 31/353 (2006.01); A61K 31/366 (2006.01); A61K 31/704 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 36/9066 (2013.01); A61K 9/0053 (2013.01); A61K 9/10 (2013.01); A61K 9/1075 (2013.01); A61K 31/047 (2013.01); A61K 31/05 (2013.01); A61K 31/12 (2013.01); A61K 31/122 (2013.01); A61K 31/19 (2013.01); A61K 31/353 (2013.01); A61K 31/366 (2013.01); A61K 31/704 (2013.01); A61K 36/16 (2013.01); A61K 36/185 (2013.01); A61K 36/258 (2013.01); A61K 36/38 (2013.01); A61K 36/53 (2013.01); A61K 36/9068 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 9/51 (2013.01); Y10S 977/773 (2013.01); Y10S 977/906 (2013.01);
Abstract

A highly bioavailable, water soluble, sustained release nanoformulation comprising a hydrophobic plant derived compound(s) in an emulsifier phase, and aqueous phase. The formulation provides sustained release of the hydrophobic plant derived compound(s) over a 24 hr time period. A process for preparation of the water soluble nanoformulation is described.


Find Patent Forward Citations

Loading…